Ke Ji

662 total citations
35 papers, 486 citations indexed

About

Ke Ji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ke Ji has authored 35 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 15 papers in Surgery. Recurrent topics in Ke Ji's work include Gastric Cancer Management and Outcomes (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Metastasis and carcinoma case studies (5 papers). Ke Ji is often cited by papers focused on Gastric Cancer Management and Outcomes (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Metastasis and carcinoma case studies (5 papers). Ke Ji collaborates with scholars based in China, Ethiopia and United Kingdom. Ke Ji's co-authors include Jiafu Ji, Wen G. Jiang, Zhaode Bu, Xiaojiang Wu, Wei Wei, Weiping Xu, Rui Wang, Xin Ji, Wenwen Zhang and Lin Ye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ke Ji

32 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Ji China 14 153 132 104 91 65 35 486
Jingmin Che China 10 173 1.1× 94 0.7× 35 0.3× 82 0.9× 54 0.8× 22 377
Masahiro Ohtaki Japan 9 62 0.4× 87 0.7× 113 1.1× 56 0.6× 47 0.7× 21 321
Takanori Yamada Japan 13 265 1.7× 23 0.2× 75 0.7× 52 0.6× 69 1.1× 29 416
Tong Zhou China 13 276 1.8× 134 1.0× 95 0.9× 183 2.0× 118 1.8× 50 629
Lois Ramsey United States 12 141 0.9× 77 0.6× 242 2.3× 120 1.3× 73 1.1× 23 438
Xin Fan China 12 183 1.2× 56 0.4× 49 0.5× 91 1.0× 80 1.2× 31 395
Henrique J. Cardoso Portugal 13 128 0.8× 53 0.4× 37 0.4× 42 0.5× 65 1.0× 40 410
Dan Kong China 14 306 2.0× 42 0.3× 42 0.4× 78 0.9× 181 2.8× 34 538
Zhichao Lin China 13 136 0.9× 98 0.7× 51 0.5× 84 0.9× 78 1.2× 37 394
Minshan Chen China 10 109 0.7× 55 0.4× 121 1.2× 82 0.9× 84 1.3× 37 480

Countries citing papers authored by Ke Ji

Since Specialization
Citations

This map shows the geographic impact of Ke Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ji more than expected).

Fields of papers citing papers by Ke Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ji. The network helps show where Ke Ji may publish in the future.

Co-authorship network of co-authors of Ke Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Ji. A scholar is included among the top collaborators of Ke Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Ji. Ke Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Kai, Xuesong Yang, Ke Ji, et al.. (2025). Clinicopathologic characteristics and prognostic factors of pure gastric neuroendocrine carcinoma patients undergoing radical surgery. BMC Cancer. 25(1). 606–606. 1 indexed citations
2.
Liu, Jun, Ke Ji, Hao Long, et al.. (2024). Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. Cellular Signalling. 120. 111198–111198. 7 indexed citations
3.
Wang, Anqiang, Ke Ji, Xin Ji, et al.. (2023). Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. The Journal of Pathology Clinical Research. 10(1). e343–e343. 4 indexed citations
4.
Yang, Xuesong, Anqiang Wang, Jialin Li, et al.. (2023). Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS). BMC Cancer. 23(1). 53–53. 5 indexed citations
5.
Ji, Ke, Yue Zhang, Ji Zhang, et al.. (2023). Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular Oncology. 47(2). 677–693. 4 indexed citations
6.
Ji, Ke, Zhaode Bu, Zhenning Wang, et al.. (2023). Nab-paclitaxel combined with oxaliplatin and S-1 as conversion therapy for advanced gastric adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 343–343.
7.
Ji, Ke & Jiafu Ji. (2023). Current status of immunotherapy in gastric cancer. 2(1).
8.
Ji, Xin, Ke Ji, Ziyu Jia, et al.. (2022). A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Yan, Yan, Zhonghua Ma, Xin Ji, et al.. (2022). A potential decision-making algorithm based on endoscopic ultrasound for staging early gastric cancer: a retrospective study. BMC Cancer. 22(1). 761–761. 3 indexed citations
11.
Chen, Jiahui, Kai Zhou, Anqiang Wang, et al.. (2021). Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer. Annals of Surgical Oncology. 28(8). 4413–4422. 11 indexed citations
12.
Zeng, Yi, et al.. (2021). Tianwang Buxin Granules Influence the Intestinal Flora in Perimenopausal Insomnia. BioMed Research International. 2021(1). 9979511–9979511. 18 indexed citations
13.
Zhang, Yinan, Yiqiang Liu, Anqiang Wang, et al.. (2021). Construction and Validation of a Risk-Scoring Model that Preoperatively Predicts Lymph Node Metastasis in Early Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6665–6672. 15 indexed citations
14.
Zhou, Kai, Anqiang Wang, Sheng Ao, et al.. (2020). The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer. 20(1). 671–671. 19 indexed citations
15.
Dai, Yuanyuan, et al.. (2020). The effect of 6-gingerol on inflammatory response and Th17/Treg balance in DSS-induced ulcerative colitis mice. Annals of Translational Medicine. 8(7). 442–442. 38 indexed citations
17.
Wang, Anqiang, Zhongwu Li, Qian Wang, et al.. (2019). Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer. Chinese Journal of Cancer Research. 31(6). 945–954. 8 indexed citations
18.
Jia, Shuqin, Tingting Qu, Xiaohong Wang, et al.. (2017). KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer. PLoS ONE. 12(4). e0175058–e0175058. 61 indexed citations
19.
Jiang, Wen G., Lin Ye, Ke Ji, et al.. (2013). Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: The pivotal role of focal adhesion kinase signalling. Oncology Reports. 30(3). 1405–1413. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026